OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
The importance of functional genomics studies in precision rheumatology	143
Editorial Board	61
Employment outcomes in systemic sclerosis	60
Update of imaging in the assessment of axial spondyloarthritis	60
Rehabilitation interventions in osteoarthritis	48
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit	43
Change of the microvascularization in systemic sclerosis, a matter of air	40
Possible future avenues for myositis therapeutics: DM, IMNM and IBM	36
Rheumatic manifestations of HIV/AIDS	32
Epidemiology of rheumatic diseases in tropical populations	31
Novel therapies in Sjögren’s disease: A systematic review of the literature	31
Pathophysiology and immunolgical basis of axial spondyloarthritis	31
The inequity of global healthcare in pediatric rheumatology	27
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus	26
Environmental factors and rheumatic diseases	25
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases	24
Index for PART A	22
The microbiome and systemic sclerosis: A review of current evidence	22
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus	22
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis	22
Genetics of osteoarthritis	21
The role of calcium crystals and their effect on osteoarthritis pathogenesis	21
Index	20
Genetics of rheumatoid arthritis	20
Editorial Board	20

Osteoporosis in 2022: Care gaps to screening and personalised medicine	20
Patient-reported outcomes in vasculitis	19
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps	19
Editorial Board	18
Novel therapies and innovation for systemic sclerosis skin ulceration	18
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights	18
Diagnostic delay in axial spondylarthritis: A lost battle?	18
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?	17
The burden of osteoarthritis: Is it a rising problem?	17
Preclinical RA: How to halt its progression	17
Systemic lupus erythematosus	17
Where is bone science taking us?	17
Imaging of crystal-induced arthropathies in 2025	17
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists	16
Pregnancy & neonatal outcomes in spondyloarthritis	16
Editorial Board	16
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	15
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment	15
Problems with “Problems with opioids beyond misuse”	15
New and future therapies: Changes in the therapeutic armamentarium for SLE	15
Role of diet in hyperuricemia and gout	15
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues	15
Calcium pyrophosphate deposition (CPPD) disease – Treatment options	14
Fecal incontinence and scleroderma: Pathogenesis and unmet needs	14
Editorial Board	14
Infection associated Vasculitides	14
Exercise in myositis: What is important, the prescription or the person?	14
Granzyme K+ CD8 T cells in autoimmunity	13
Editorial Board	13
Pregnancy in systemic lupus erythematosus	13
Risk for osteoporosis and fracture with glucocorticoids	13
Innovations in systemic sclerosis	12
Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions	12
Index	12
Regenerative methods in osteoarthritis	12
Best practice and research advances in many aspects of rheumatology	12
Review for best practice in clinical rheumatology juvenile systemic sclerosis – Updates and practice points	12
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment	12
What the rheumatologist needs to know about skin biopsy	11
Treatment of rheumatic adverse events of cancer immunotherapy	11
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances	11
Synovial fluid analysis: Relevance for daily clinical practice	11
Pharmacogenetics of therapies in rheumatoid arthritis: An update	11
Impact of sex and gender on axSpA diagnosis and outcomes	10
Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis	10
Idiopathic inflammatory myopathies: Progress, challenges, and future perspectives	10
Musculoskeletal complications in sickle cell disease: Pathophysiology, diagnosis and management	9
A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis	9
Index	9
When are patients with osteoarthritis referred for surgery?	9

Muscle imaging in myositis: MRI, US, and PET	9
Practical utilization of sonography for the assessment of muscle diseases in rheumatology	9
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future	9
Pain in osteoarthritis from a symptom to a disease	9
Editorial Board	9
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus	9
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	8
TNFR2 signalling in inflammatory diseases	8
CARD9 in the pathogenesis of axial spondyloarthritis	8
Interferonopathies: From concept to clinical practice	8
Recent targets of osteoarthritis research	8
Femoroacetabular impingement – What the rheumatologist needs to know	8
Pathogenesis of calcium pyrophosphate deposition disease	8
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	8
Pain mechanisms for the practicing rheumatologist	7
Preface: Pediatric rheumatology	7
Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies	7
Pain syndromes	7
Editorial Board	6
Imaging in sarcoid disease	6
Tropical pyomyositis	6
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission	6
Novel therapies in axial spondyloarthritis	6
The global burden of fragility fractures – what are the differences, and where are the gaps	6
Insights into the genetic landscape of systemic sclerosis	6
Interstitial lung disease imaging for autoimmune diseases	5
Myofascial pain – A major player in musculoskeletal pain	5
Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes	5
Cancer and myositis: Who, when, and how to screen	5
Pre-RA: Can early diagnosis lead to prevention?	5
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	5
Best practice in rheumatology new developments in ultrasound and MRI imaging of pediatric rheumatic diseases	5
Treatment overview of axial spondyloarthritis in 2023	5
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)	5
Cardiovascular risk in vasculitis	5
Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases	5
Musculoskeletal manifestations in leprosy	5
Non-coding DNA variants for risk in lupus	5
How to treat monogenic SLE?	4
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?	4
Highlights of advancement in Rheumatoid Arthritis research and clinical practice	4
What is new in pharmacological treatment for osteoarthritis?	4
Practical approaches for clinicians in chronic pain management: Strategies and solutions	4
Challenges in the diagnosis of axial spondyloarthritis	4
Editorial Board	4
Vascular ultrasound in rheumatology practice	4
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question	4
Microbiota and immune dynamics in rheumatoid arthritis: Mechanisms and therapeutic potential	4
Genetics of vasculitis	4
Osteoporosis and fragility fractures – Why is there still avoidable disability and death?	4
Relapsing polychondritis: Best Practice & Clinical Rheumatology	3
Deficiency of adenosine deaminase 2 (DADA2): Review	3
Clinical utility of ultrasound and MRI in rheumatoid arthritis: An expert review	3
Cervicogenic headache – How to recognize and treat	3
Temporal artery biopsy	3
Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease	3
“Inflammatory or non-inflammatory pain in inflammatory arthritis – How to differentiate it?”	3
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon	3
Management of Takayasu arteritis	3
Antiphospholipid syndrome in children	3
Assessment of disease activity and damage in SLE: Are we there yet?	3
Structural disease modification in axial spondyloarthritis	3
Systemic lupus erythematosus and damage: What has changed over the past 20 years?	3
B cell activation and autoantibody production in autoimmune diseases	3